SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's gains on entering into definitive agreement with BioDelivery Sciences International

05 Aug 2021 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 4789.25, up by 17.95 points or 0.38% from its previous closing of Rs. 4771.30 on the BSE.

The scrip opened at Rs. 4808.00 and has touched a high and low of Rs. 4808.00 and Rs. 4744.00 respectively. So far 0.21 lakh shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5,613.65 on 07-Jul-2021 and a 52 week low of Rs. 4,135.90 on 19-Mar-2021.

Last one week high and low of the scrip stood at Rs. 4809.75 and Rs. 4679.90 respectively. The current market cap of the company is Rs. 79,666.81 crore.

The promoters holding in the company stood at 26.73%, while Institutions and Non-Institutions held 44.78% and 28.49% respectively.

Dr Reddy's Laboratories has entered into a definitive agreement with BioDelivery Sciences International, Inc., to sell its US and Canada territory rights for Elyxyb 25 mg/mL to the US-based firm. Elyxyb is indicated for the acute treatment of migraine with or without aura in adults.

Under the terms of the pact, Dr Reddy's will receive $6 million upfront upon closing, followed by $ 9 million one year from closing. Further, it is eligible to receive event-based, sales-based milestones and quarterly earn-out payments.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1279.70 -13.55 (-1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×